ACCC conducted a national survey to improve understanding on how patients with stage III/IV NSCLC were diagnosed and managed across different practice settings. Presented at the 2020 ASCO Virtual Scientific Program
![[Abstract e19195] Improving Care for Patients with Stage III/IV NSCLC: Learnings for Multidisciplinary Teams from the ACCC National Quality Survey](https://cdn.sanity.io/images/0vv8moc6/accc-cancer/e8a1bf7bd8e88a3ee1f84a6bb790c523360d9986-238x310.png?fit=crop&auto=format)
Presented at the American Society of Clinical Oncology 2020 (#ASCO20) Virtual Scientific Program, May 29 to May 31, 2020.
Authors
Ravi Salgia, Leigh Boehmer, Catherine Celestin, Judy Yu, David R. Spigel; The University of Chicago, Chicago, IL; Association of Cancer Care Centers, Rockville, MD; AstraZeneca, Gaithersburg, MD; Sarah Cannon Research Institute, Nashville, TN.
Refinement of the multidisciplinary team (MDT) approach continues to offer significant potential for improving the quality of non-small cell lung cancer (NSCLC) care and adherence to guideline-recommended protocols. This opportunity arises, in part, from insufficient characterization of MDT practice patterns and barriers to optimal care provision within U.S. cancer programs. The Association of Cancer Care Centers (ACCC), therefore, conducted a national survey to improve understanding on how patients with stage III/IV NSCLC were diagnosed and managed across different practice settings, with the aim of informing the design and execution of process-improvement plans to address identified barriers.
Download Infographic
ASCO Abstract: What Defines Quality Lung Cancer Care?
June 12, 2020
